How should a firm palpable breast mass be evaluated and managed?

Evaluation and Management of a Firm Palpable Breast Mass

A firm palpable breast mass requires immediate imaging evaluation with the specific modality determined by patient age, followed by image-guided core needle biopsy for any suspicious findings to definitively rule out malignancy.

Age-Based Imaging Algorithm

Women ≥40 Years Old

• Start with diagnostic mammography (or digital breast tomosynthesis), followed by targeted ultrasound in most cases 1
• Mammography alone has 86-91% sensitivity for palpable abnormalities 1
• Ultrasound is essential as the next step unless mammography shows a clearly benign correlate (oil cyst, hamartoma, degenerating fibroadenoma, lipoma, benign lymph node) 1
• Ultrasound can identify mammographically occult lesions and definitively characterize certain findings 1

Women <30 Years Old

• Begin with ultrasound as the primary imaging modality 1
• Breast cancer incidence is <1% in this age group, and dense breast tissue reduces mammographic sensitivity 1
• Add mammography or DBT only if ultrasound shows suspicious findings, to better delineate disease extent and identify features of malignancy 1

Women 30-39 Years Old

• Either ultrasound or diagnostic mammography can be performed first 1
• Ultrasound maintains high sensitivity in women <40 years old 2
• The choice depends on clinical suspicion and radiologist discretion 3

Tissue Sampling Strategy

When Biopsy is Mandatory

• Any suspicious mass on mammography or ultrasound requires tissue sampling 1
• Never allow negative imaging to overrule a highly suspicious clinical finding 1
• The negative predictive value of mammography with ultrasound ranges from 97.4-100%, but this does not eliminate the need for biopsy when clinical suspicion is high 1

Biopsy Technique

• Image-guided core needle biopsy is superior to fine-needle aspiration 1
• Core biopsy provides better sensitivity, specificity, correct histological grading, and allows hormone receptor testing 1
• Ultrasound guidance is preferred over stereotactic when the lesion is visible on both modalities due to patient comfort, efficiency, economy, no ionizing radiation, and real-time needle visualization 1
• Image-guided biopsy is preferred even for palpable lesions because it confirms biopsy accuracy and allows marker clip placement 1

Management of Benign-Appearing Masses

Definitively Benign on Imaging

• If ultrasound definitively characterizes the mass as benign (simple cyst, benign lymph node, duct ectasia, lipoma), clinical follow-up alone is appropriate 1
• No imaging follow-up or tissue sampling is needed 1

Probably Benign Features

• Short-interval follow-up (6-month intervals for 2 years) may be appropriate for palpable solid masses with benign ultrasound features if clinical examination also suggests benign etiology 1
• Benign ultrasound features include: oval/round shape, well-defined margins, homogeneous echogenicity, parallel orientation to chest wall, no posterior acoustic shadowing 1
• This approach is supported by evidence showing low cancer incidence in properly characterized probably benign palpable masses 1, 4

Critical Pitfalls to Avoid

• Never perform biopsy before imaging, as biopsy changes can confuse, alter, or obscure image interpretation 1
• Do not rely on physical examination alone - even experienced examiners show significant disagreement (only 73% agreement on need for biopsy in proven malignancies) 1
• MRI has no role in initial evaluation of palpable masses - it is not cost-effective and lacks supporting evidence for this indication 1, 3
• Nuclear medicine imaging (FDG-PEM, Tc-99m sestamibi MBI) has no role in evaluating palpable masses 1
• Physical examination features are unreliable: only 58% of palpable cysts are correctly identified by palpation 1

Key Clinical Considerations

• Symptomatic breast cancers tend to be more aggressive with poorer prognosis than screen-detected cancers 1, 2
• Imaging should occur before any tissue sampling to avoid diagnostic confusion 1
• The radiologist must establish concordance between imaging findings and the clinically detected mass 1
• Digital breast tomosynthesis may be particularly useful in women with dense breasts 1